Use access key #2 to skip to page content.
$80.62 -6.91 (-7.89%)
10/6/2008 4:00 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View Ticker Page (DNA)

Results 21 - 30 of 269 :   12345Next »

Recs

1

Avatar StockMarketBeat (61.26) Submitted: 7/14/07 1:19 PM : Outperform Start Price: $75.69 DNA Score: 38.95

The good news: During the quarter, the company began eight Phase III clinical trials. Those studies include Lucentis as a possible treatment for eye problems caused by diabetes and Avastin for a specific form of lung cancer and as a second-line treat...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar pbb13 (< 20) Submitted: 3/21/07 1:29 PM : Outperform Start Price: $84.07 DNA Score: 21.75

True leader in their space and will be rewarded for it.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar datalker (< 20) Submitted: 7/19/07 12:48 PM : Outperform Start Price: $75.19 DNA Score: 39.78

Look for the long term growth rate to contract, as dosing of existing treatments is reduced, but DNA is not Amgen. DNA has a pipeline and licensing partnerships, and new drugs are still ramping. I expect some more multiple contraction, but I think ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar bnscBill (55.25) Submitted: 10/20/06 5:24 PM : Outperform Start Price: $79.15 DNA Score: 22.14

My friend works for this company. He likes his job alot. With all the good products and my estimation of my friends happiness with his job, I expect this company to continue to do good things in years to come.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar csguernsey (80.91) Submitted: 6/16/07 4:42 PM : Outperform Start Price: $77.41 DNA Score: 35.87

Biotech is a field that is just hitting it's stride and which will accelerate exponentially over the coming decades as the fundamental understanding of biological processes matures. As such, it is a proimisin g long-term investment.

In ad...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar docmase (57.31) Submitted: 6/15/07 11:20 PM : Outperform Start Price: $77.41 DNA Score: 35.87

Genentech has a number of interesting products in the pipeline that hold the potential to change the standard of care in the treatment of various cancers including prostate, breast, ovarian, lymphoma.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar grow76 (99.32) Submitted: 12/13/06 12:54 PM : Outperform Start Price: $82.58 DNA Score: 24.09

Biotech leader that has an arsenal of drugs making a large pile of money. Drugs like Avastin are being applied to new cancers the drug was not originally targeted for with success. This company has a very bright future. Will probably acquire some sma...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar topsailonmymind (20.21) Submitted: 4/08/07 7:24 PM : Outperform Start Price: $83.40 DNA Score: 24.27

Genetech has been the leader in the Biotech industry. Thye have a great pipeline. Corporate culture continues to foster innovation and development. Leadership is solid. Good fundamentals and projected growth rates (21 analysts with avg projected ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar racetothefinish (33.93) Submitted: 3/27/07 12:31 PM : Outperform Start Price: $82.86 DNA Score: 23.91

world class company., low price to growth, will benefit from amgn's problems

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar HighHopesInSD (43.17) Submitted: 4/07/08 5:01 PM : Outperform Start Price: $78.76 DNA Score: 23.81

Sales have risen every year for the past 10 years. EPS has risen every year for the past 7 years. The profit margin has risen every year for the past 7 years. The ROE has risen every year for the past 4 years. The debt has fallen in each of the p...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners